We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
September 2020
IQ BioCMC LG Subvisible Particles Working Group Case Study presents a Multi-company Assessment of Submicron Particle Levels in Biotechnology-derived Protein Products
June 2020
IQ DSLG Coprocessed API Working Group presents webinar on recent perspective paper - Recent Advances in Coprocessed APIs & Proposals for Enabling Commercialization of These Transformative Technologies
There are currently no events to display